The National Institute of Neurological Disorders and Stroke (NINDS) offers this Small Business Technology Transfer (STTR) grant for Small Business Concerns (SBCs). The purpose is to fund investigator-initiated exploratory clinical trials focusing on products and therapies relevant to NINDS’s mission. Eligible projects can evaluate drugs, biologics, devices, diagnostics, or surgical, behavioral, and rehabilitation therapies. This program specifically supports STTR Phase II and Fast-Track applications. STTR Phase I applications are only accepted when submitted as part of a Fast-track application. This grant provides a vital vehicle for small businesses to advance innovative neurological research from early-stage development to clinical evaluation.
Opportunity ID: 351150
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | PAR-24-044 |
| Funding Opportunity Title: | NINDS Exploratory Clinical Trials for Small Business (R41/R42 Clinical Trial Required) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.853 — Extramural Research Programs in the Neurosciences and Neurological Disorders |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Nov 27, 2023 |
| Last Updated Date: | Nov 27, 2023 |
| Original Closing Date for Applications: | Sep 05, 2026 |
| Current Closing Date for Applications: | Sep 05, 2026 |
| Archive Date: | Oct 11, 2026 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Small businesses |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, may be allowed. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | (Reissue of PAR-18-617) The purpose of this funding opportunity announcement (FOA) is to provide a vehicle for Small Business Concerns (SBCs) submitting Small Business Technology Transfer (STTR) grant applications for investigator-initiated exploratory clinical trials to the National Institute of Neurological Disorders and Stroke (NINDS). The projects must focus on products related to the mission and goals of the NINDS and may evaluate drugs, biologics, devices, or diagnostics, as well as surgical, behavioral or rehabilitation therapies. Only STTR Phase II and Fast-Track applications are supported under this program. STTR Phase I applications are only accepted as part of a Fast-track application. |
| Link to Additional Information: | https://grants.nih.gov/grants/guide/pa-files/PAR-24-044.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH Grants Information
grantsinfo@nih.gov Email:grantsinfo@nih.gov |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
Folder 351150 Full Announcement-PAR-24-044 -> PAR-24-044-Full-Announcement.pdf
Packages
| Agency Contact Information: | NIH Grants Information grantsinfo@nih.gov Email: grantsinfo@nih.gov |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-H | Use for due dates on or before January 24, 2025 | PKG00283905 | Dec 05, 2023 | Jan 24, 2025 | View | |
| FORMS-I | Use for due dates on or after January 25, 2025 | PKG00289086 | Nov 26, 2024 | Sep 05, 2026 | View |
Package 1
Mandatory forms
351150 RR_SF424_5_0-5.0.pdf
351150 PHS398_CoverPageSupplement_5_0-5.0.pdf
351150 RR_OtherProjectInfo_1_4-1.4.pdf
351150 PerformanceSite_4_0-4.0.pdf
351150 RR_KeyPersonExpanded_4_0-4.0.pdf
351150 RR_Budget_3_0-3.0.pdf
351150 RR_SubawardBudget30_3_0-3.0.pdf
351150 PHS398_ResearchPlan_5_0-5.0.pdf
351150 SBIR_STTR_Information_3_0-3.0.pdf
351150 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
351150 PHS_AssignmentRequestForm_4_0-4.0.pdf
Package 2
Mandatory forms
351150 RR_SF424_5_0-5.0.pdf
351150 PHS398_CoverPageSupplement_5_0-5.0.pdf
351150 RR_OtherProjectInfo_1_4-1.4.pdf
351150 PerformanceSite_4_0-4.0.pdf
351150 RR_KeyPersonExpanded_4_0-4.0.pdf
351150 RR_Budget_3_0-3.0.pdf
351150 RR_SubawardBudget30_3_0-3.0.pdf
351150 PHS398_ResearchPlan_5_0-5.0.pdf
351150 SBIR_STTR_Information_3_0-3.0.pdf
351150 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
351150 PHS_AssignmentRequestForm_3_0-3.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
